Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager
Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA
PAR:DIM
Watchlist
Price: 181.9 EUR -1.36% Market Closed
Market Cap: 17.7B EUR
Have any thoughts about
Sartorius Stedim Biotech SA?
Write Note

Net Margin
Sartorius Stedim Biotech SA

6.2%
Current
17%
Average
-0.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.2%
=
Net Income
169.2m
/
Revenue
2.7B

Net Margin Across Competitors

Country FR
Market Cap 17.7B EUR
Net Margin
6%
Country US
Market Cap 1.4T USD
Net Margin
9%
Country US
Market Cap 211.1B USD
Net Margin
14%
Country US
Market Cap 177.9B USD
Net Margin
18%
Country KR
Market Cap 71.2T KRW
Net Margin
24%
Country CH
Market Cap 39.5B CHF
Net Margin
9%
Country US
Market Cap 39.9B USD
Net Margin
9%
Country US
Market Cap 39.4B USD
Net Margin
22%
Country US
Market Cap 28.1B USD
Net Margin
21%
Country US
Market Cap 24B USD
Net Margin
-36%
Country US
Market Cap 23.7B USD
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Sartorius Stedim Biotech SA.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.2%
=
Net Income
169.2m
/
Revenue
2.7B
What is the Net Margin of Sartorius Stedim Biotech SA?

Based on Sartorius Stedim Biotech SA's most recent financial statements, the company has Net Margin of 6.2%.